MTOR and hepatocellular carcinoma: Although no targeted agents with well-established radiosensitizing activity against HCC have yet been identified, promising candidates include inhibitors of heat-shock proteins [44], EGFR [45], and the PI3K-AKT-mTOR pathway [46].